Central Serous Chorioretinopathy Treated by Modified Photodynamic Therapy

NCT01019668 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Central Serous Chorioretinopathy

Interventions

DRUG: Verteporfin PDT, half-dose
DRUG: verteporfin PDT, half-fluence

Sponsor

Shin Kong Wu Ho-Su Memorial Hospital